GlassScriptPhysician profile
Samantha Gamarra
NPI 1720854110
$719.45
in general payments reported to CMS, 2019-2025
14 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $232 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $140.81 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $98.85 | 2024-2025 | Orgovyx |
| Janssen Biotech, INC. | $90.41 | 2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $79.50 | 2024-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $63.54 | 2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $54.21 | 2025 | Trelstar |
| Boston Scientific Corporation | $46.08 | 2024-2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $31.74 | 2025 | |
| Coloplast Corp | $24.13 | 2025 | |
| Myriad Genetic Laboratories, INC. | $21.54 | 2024 | Myrisk |
| Immunitybio, INC. | $21.49 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.97 | 2025 | |
| Calyxo, INC. | $15.75 | 2024 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $12.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Gamarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.